Dr. Jerome Kim (left), Director General of IVI and Dr. Quehn Park, Commander of AFMRI

July 12, 2019 – SEOUL, South Korea. Today IVI exchanged a memorandum of understanding with the Armed Forces Medical Research Institute (AFMRI), the Korean military’s institution dedicated solely to medical research and development, prevention of diseases, and promotion of health of military personnel.

Through this partnership, IVI and AFMRI will seek the exchange of research resources and close cooperation for the development of a vaccine against human adenovirus type 55, which is reported to cause outbreaks of acute respiratory diseases among military trainees and in school populations around the world. Both parties will also aim to facilitate discussions to explore and conduct joint research projects, and to support the vaccination of the Armed Forces.

IVI is looking forward to working together with AFMRI and bringing together scientists and humanitarians in our shared mission to save lives through innovative vaccine research and development.

Participants at the MOU signing ceremony from IVI and AFMRI Institute pose for a commemorative photo